Amyris Fails To Get Final OK On $190M DIP Loan
Bankrupt biochemical company Amyris Inc. failed to get final court approval Thursday for its $190 million post-petition financing after cannabinoid maker and creditor Lavvan Inc. raised a series of issues that...To view the full article, register now.
Already a subscriber? Click here to view full article